Completed PHASE4 INTERVENTIONAL 2-arm NCT02024425

Functional Bioactive Supplement Effect in Lost Weight Treatment (ALIBIRDII)

A Randomized, Double-blind Trial to Evaluate the Effect of a Functional Bioactive Supplement Associated With a Hypocaloric Equilibrated Diet to Treatment of Obese and Overweight Individuals

Sponsor: Instituto de Investigación Hospital Universitario La Paz

Conditions Obesity and Overweight

Interventions Control supplement Functional bioactive supplement

Updated 5 times since 2017 Last updated: Nov 18, 2015 Started: Sep 30, 2013 Primary completion: Dec 31, 2013 Completion: Jan 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Obesity and Overweight, this trial is completed. The trial is conducted by Instituto de Investigación Hospital Universitario La Paz and has accumulated 5 data snapshots since 2013. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Sep 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Instituto de Investigación Hospital Universitario La Paz

Data source: Instituto de Investigación Hospital Universitario La Paz

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Madrid, Spain